Skip to main content
OpenTrials
Completed

NCT Number: NCT07790016

Photobiomodulation on NMES-Induced Muscle Fatigue and Damage

Neuromuscular electrical stimulation (NMES) is effective for strength training and rehabilitation, but non-selective motor unit recruitment often induces rapid fatigue, discomfort, and muscle damage. Photobiomodulation therapy (PBMT) has been proposed to attenuate muscle fatigue and accelerate recovery, yet evidence regarding its acute prophylactic effects against NMES-induced fatigue remains limited. This randomized, single-blind, sham-controlled crossover pilot trial evaluates the acute effects of pre-exercise PBMT on knee extensor neuromuscular fatigability, muscle damage, discomfort, and functional recovery following a standardized NMES fatigue protocol in healthy adults.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Muscle Fatigue (C23.888.592.612.612) Delayed Onset Muscle Soreness (DOMS) Muscle Damage Neuromuscular Electrical Stimulation (NMES) Photobiomodulation (PBM)

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Laboratório de Pesquisa do Exercício

Porto Alegre, Rio Grande do Sul, 90690200, Brazil

About this study

This study utilizes a randomized, single-blind, sham-controlled crossover design to evaluate the acute effects of photobiomodulation therapy (PBMT) on neuromuscular electrical stimulation (NMES)-induced fatigue in healthy individuals.

Participants undergo testing across two intervention blocks separated by a 7-day washout period between limbs:

Intervention Phase: Five minutes prior to an electrically evoked fatigue protocol, participants receive either active PBMT (multi-diode GaAlAs laser cluster; 810 nm; 200 mW per diode; 30 J per point across 8 quadriceps sites; total energy dose: 240 J) or sham PBMT (identical positioning with the device inactive and acoustic blinding).

NMES Fatigue Protocol: The protocol is performed on an isokinetic dynamometer with the knee fixed at 90° flexion. Rectangular biphasic symmetrical pulses (100 Hz; 1 ms pulse width; 5 s on, 10 s off) are delivered over 20 minutes to evoke 60 isometric contractions adjusted to an initial torque of 20% maximal voluntary isometric contraction (MVIC).

Evaluation Timeline: Neuromuscular and functional assessments are conducted at Baseline, Immediately Post-Fatigue, and at 24, 48, and 72 hours post-protocol. Tests include maximal voluntary isometric torque, resting supramaximal evoked twitches, transverse ultrasound echointensity of the rectus femoris and vastus lateralis, pressure pain thresholds via algometry, Visual Analog Scales for discomfort, and horizontal Single Hop Test performance.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy male and female adults aged between 18 and 40 years.
  • Engaging in regular physical activity (minimum of twice a week).
  • No history of hospitalization for COVID-19 in the past 12 months.
  • Demonstrated ability to tolerate neuromuscular electrical stimulation (NMES).
  • Capable of fully understanding and complying with the experimental protocol and procedures.

Exclusion criteria

  • Presence of any sensory impairments or neurological alterations.
  • Ingestion of caffeine, coffee, energy drinks, or other stimulants in the 12 hours preceding the testing sessions.
  • Body Mass Index (BMI) greater than 30 kg/m².
  • Any medical contraindication to performing maximal physical exertion or presenting an abnormal cardiovascular/blood pressure response after maximal effort.

Treatment and study plan

Photobiomodulation therapy (PBMT)

Device

Multi-diode cluster probe (GaAlAs laser; 5 diodes; wavelength: 810 nm; power output: 200 mW per diode; continuous mode) applied across 8 points over the quadriceps femoris (3 on rectus femoris, 3 on vastus lateralis, and 2 on vastus medialis) for 30 seconds per point (30 J/point), delivering a total energy dose of 240 J per limb.

Sham photobiomodulation

Device

Identical probe positioning over the 8 quadriceps locations for 30 seconds per point with the laser device completely turned off. Auditory headphones are used to blind participants against sound cues.

Primary outcomes

  1. Maximal Voluntary Isometric Contraction (MVIC) Torque

    Time frame: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.

    Knee extensor peak isometric torque measured on an isokinetic dynamometer (Biodex System 3 Pro) during 5-second maximal isometric contractions with the knee fixed at 90° flexion, expressed in Newton-meters (N.m).

Secondary outcomes

  1. Muscle Damage via Ultrasound Echointensity

    Time frame: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.

    Quantitative grayscale histogram analysis (0 = black, 255 = white) of transverse ultrasound images (ImageJ software) of the rectus femoris (at 40%, 50%, and 60% of the femur length) and vastus lateralis (at 50% of the femur length) muscles to assess structural muscle damage.

  2. Supramaximal Evoked Twitch Torque

    Time frame: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.

    Knee extensor evoked torque produced by single supramaximal electrical twitches (1 Hz, 500 µs rectangular biphasic pulses at rest) delivered to the rectus femoris motor point, measured in Newton-meters (N.m) on the isokinetic dynamometer to evaluate peripheral muscle fatigue.

  3. Evoked Neuromuscular Efficiency

    Time frame: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.

    Ratio between the supramaximal evoked twitch peak torque and the applied current intensity (Nm/mA) during resting single pulses.

  4. Sitting Muscle Discomfort

    Time frame: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.

    Subjective sensation of discomfort/pain in the quadriceps femoris evaluated while seated at rest using a 10 cm Visual Analog Scale (VAS), where 0 cm represents 'no discomfort' and 10 cm represents 'maximum discomfort'.

  5. Pain Pressure Threshold (PPT)

    Time frame: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.

    Mechanical pain sensitivity measured using a digital pressure algometer (applied at 90° in kgf/cm²) over the rectus femoris, vastus lateralis, and vastus medialis muscle bellies to identify delayed onset muscle soreness.

  6. Single Hop Test (SHT) Functional Performance

    Time frame: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.

    Maximal horizontal single-leg hop distance normalized to limb length, calculated as: [Hop Distance (cm) / Limb Length (cm)] * 100.

  7. Discomfort During Stair Ascent and Descent

    Time frame: Baseline, Immediately post-fatigue protocol, 24 hours, 48 hours, and 72 hours post-fatigue.

    Level of discomfort reported on a 10 cm Visual Analog Scale (VAS) immediately after ascending and descending a 10-step staircase.

  8. Total Mechanical Work During Fatigue Protocol

    Time frame: During the 20-minute NMES fatigue protocol.

    Cumulative mechanical work quantified by the sum of the torque-time integral (TTI) across all 60 evoked contractions during the 20-minute NMES protocol (expressed in N.m.s).

  9. Fatigue Index (% Work Decline)

    Time frame: During the 20-minute NMES fatigue protocol.

    Percentage reduction in work performed between the first 5 evoked contractions and the last 5 evoked contractions of the NMES fatigue protocol, calculated as: [(Initial Work - Final Work) / Initial Work] * 100.

Sponsors and collaborators

Lead sponsor

Federal University of Rio Grande do Sul

Other

Collaborators

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Registry information

Official study title

Effects of Photobiomodulation and Stimulation Sites on Muscle Fatigue and Damage Induced by Neuromuscular Electrical Stimulation in Healthy Individuals

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Aug 27, 2026
Registry last updated
Aug 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.